| Literature DB >> 25592100 |
Turhan Turan1, Ümit Menteşe, Mustafa Tarık Ağaç, Ali Rıza Akyüz, Selim Kul, Ahmet Çağrı Aykan, Hüseyin Bektaş, Levent Korkmaz, Seda Öztaş Menteşe, İhsan Dursun, Şükrü Çelik.
Abstract
OBJECTIVE: Oxidative stress plays a major role in the development of atherosclerosis. However, the relationship between oxidative stress and complexity and intensity of coronary artery disease is less clear. The aim of this study is to assess the relationship between oxidative stress markers and the complexity and intensity of coronary artery disease in patients with acute coronary syndrome (ACS).Entities:
Mesh:
Year: 2014 PMID: 25592100 PMCID: PMC5336964 DOI: 10.5152/akd.2014.5761
Source DB: PubMed Journal: Anatol J Cardiol ISSN: 2149-2263 Impact factor: 1.596
Baseline characteristics of the study population (n=67)
| Age, years | 62±10 |
| Male/female, n (%) | 53 (79.1%)/14 (20.9%) |
| BSA, m2 | 1.8 (1.4-1.9) |
| Diabetes mellitus, n (%) | 16 (23.9%) |
| Hypertension, n (%) | 44 (65.7%) |
| PAD, n (%) | 2 (3%) |
| Smokers, n (%) | 23 (34.3%) |
| Statin use, n (%) | 16 (23.9%) |
| ACEI/ARB use, n (%) | 23 (34.3%) |
| Beta-blocker use, n (%) | 17 (25.4%) |
| Nitrate use, n (%) | 6 (9%) |
| LDL-cholesterol, mg/dL | 134.1±34.4 |
| Urea, mg/dL | 39.3±12.6 |
| Creatinine, mg/dL | 0.94±0.35 |
| SYNTAX score | 22.1±9.6 |
| Gensini score | 70.4±35.9 |
ACEI/ARB - angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; BSA - body surface area; LDL - low-density lipoprotein; PAD - peripheral arterial disease.
Data expressed as median (interquartile range)
Comparison of clinical characteristics and serum oxidative markers in low and moderate-high SYNTAX scores
| Low SS (<22) (n=37) | Moderate/high SS (>22) (n=30) | ||
|---|---|---|---|
| Age, years | 59.5±9.5 | 65.1±9.9 | 0.02 |
| Male gender | 29 | 24 | NS |
| BSA, m2 | 1.8 (1.4-1.9) | 1.8 (1.3-1.9) | NS |
| Diabetes mellitus, n | 8 | 8 | NS |
| Hypertension, n | 26 | 18 | NS |
| PAD, n | 0 | 2 | NS |
| Smokers, n | 12 | 11 | NS |
| Statin use, n | 10 | 6 | NS |
| ACEI/ARB use, n | 15 | 8 | NS |
| Beta-blocker use, n | 12 | 5 | NS |
| Nitrate use, n | 6 | 0 | NS |
| LDL-cholesterol, mg/dL | 136.5±34.2 | 131 ±35.1 | NS |
| Urea, mg/dL | 38 (31.2-47.7) | 38(35-41) | NS |
| Creatinine, mg/dL | 0.95±0.41 | 0.92±0.25 | NS |
| TOS, μmol H2O2 equivalent/L | 7.8 (6-10.8) | 10.2 (5.8-17.7) | 0.1 |
| TAC, μmol Trolox equivalent/L | 1.44±0.49 | 1.47±0.53 | 0.8 |
| OSI | 0.56 (0.37-0.88) | 0.68 (0.34-1.55) | 0.3 |
ACEI/ARB - angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; BSA-body surface area; LDL - low-density lipoprotein; NS - non-significant; OSI - oxidative stress index; PAD - peripheral arterial disease; SS - SYNTAX score; TAC - total antioxidant capacity of plasma; TOS - total oxidant status.
Skew-distributed continuous variables were compared using Mann-Whitney U test
Figure 1Oxidative stress markers [total antioxidant capacity (TAC), total oxidative stress (TOS), and oxidative stress index (OSI)] in subjects with moderate to high (≥22) and low (<22) SYNTAX score (SS)
Figure 2Oxidative stress markers [total antioxidant capacity (TAC), total oxidative stress (TOS), and oxidative stress index (OSI)] in subjects with intensive CAD (Gensini score ≥64) and less intensive CAD (Gensini score <64)
Comparison of clinical characteristics and serum oxidative markers in groups 1 and 2
| Group 1 (GS <64) (n=32) | Group 1 (GS ≥64) (n=35) | ||
|---|---|---|---|
| Age, years | 59.2±9.2 | 64.5±10.2 | 0.03 |
| Male gender | 25 | 28 | NS |
| BSA, m2 | 1.8 (1.6-1.9) | 1.8 (1.0-1.9) | NS |
| Diabetes mellitus, n | 8 | 8 | NS |
| Hypertension, n | 19 | 25 | NS |
| PAD, n | 0 | 2 | NS |
| Smokers, n | 12 | 11 | NS |
| Statin use, n | 7 | 9 | NS |
| ACEI/ARB use, n | 11 | 12 | NS |
| Beta-blocker use, n | 9 | 8 | NS |
| Nitrate use, n | 3 | 3 | NS |
| LDL-cholesterol, mg/dL | 130±36.1 | 138.1±32.7 | NS |
| Urea, mg/dL | 38 (31-45.5) | 38 (32-43) | NS |
| Creatinine, mg/dL | 0.96±0.41 | 0.91±0.27 | NS |
| TOS, μmol H2O2 equivalent/L | 6.8 (5.4-10.2) | 10.65 (6.59-16.59) | 0.005 |
| TAC, μmol Trolox equivalent/L | 1.46±0.5 | 1.45±0.51 | 0.93 |
| OSI | 0.52 (0.31-0.77) | 0.68 (0.40-1.50) | 0.04 |
ACEI/ARB - angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; BSA - body surface area; GS - Gensini score; LDL - low-density lipoprotein; NS - nonsignificant; OSI - oxidative stress index; PAD - peripheral arterial disease; TAC - total antioxidant capacity of plasma; TOS - total oxidant status.
Skew-distributed continuous variables were compared using Mann-Whitney U-test